News Digital Health App Tracks Pain Progress With Neurostimulation Therapy By Brian Park, PharmD Publish Date January 14, 2021
Drugs in the Pipeline Locally-Delivered Sitaxsentan Designated Orphan Drug for Systemic Sclerosis By Brian Park, PharmD Publish Date January 13, 2021
News Kineret Approved for Deficiency of IL-1 Receptor Antagonist By Brian Park, PharmD Publish Date December 28, 2020
News Continuing Treatment Not Beneficial After 5 Years of Bisphosphonates Publish Date December 17, 2020
Drugs in the Pipeline Antifibrotic Therapy Gets Orphan Drug Status for Systemic Sclerosis By Brian Park, PharmD Publish Date December 1, 2020
Drugs in the Pipeline FDA to Review AVT02, a High Concentration Biosimilar to Adalimumab By Brian Park, PharmD Publish Date November 20, 2020
News RediTrex Now Available for RA, pJIA, Psoriasis Treatment By Diana Ernst, RPh Publish Date November 18, 2020
News Study Supports Switching Between Upadacitinib and Adalimumab in RA By Amit Akirov, MD Publish Date November 17, 2020
News Synovitis Reduction Observed With Secukinumab in Psoriatic Arthritis Trial By Brian Park, PharmD Publish Date November 5, 2020
News Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions Publish Date October 19, 2020
Drugs in the Pipeline Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy By Brian Park, PharmD Publish Date October 5, 2020
News Simponi Aria Approved for Polyarticular JIA, Pediatric Psoriatic Arthritis By Brian Park, PharmD Publish Date October 1, 2020
Drugs in the Pipeline Elezanumab Granted Orphan Drug, Fast Track Designations for Spinal Cord Injury By Brian Park, PharmD Publish Date September 30, 2020
News Xeljanz Approved for Active Polyarticular Course Juvenile Idiopathic Arthritis By Brian Park, PharmD Publish Date September 29, 2020